A 68-Year-Old Female with Advanced Renal Cell Carcinoma - Episode 4

Role of Cabozantinib and Nivolumab in Advanced RCC

Dr Daniel J George reviews long term follow up data from the CHECKMATE 9ER and the implications of the data in the treatment paradigm for patients with advanced renal cell carcinoma.